Invesco
LPCN icon

Invesco’s Lipocine LPCN Stock Holding History

Invesco’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-62,632
Closed -$4.15M – 3708
2017
Q1 		$4.15M Sell
62,632
-687
-1% -$44.5K ﹤0.01% 2113
2016
Q4 		$3.96M Buy
63,319
+52
+0.1% +$3.29K ﹤0.01% 2120
2016
Q3 		$4.8M Sell
63,267
-4
-0% -$248 ﹤0.01% 2005
2016
Q2 		$3.27M Buy
63,271
+36
+0.1% +$5.58K ﹤0.01% 2203
2016
Q1 		$10.9M Hold
63,235
– – ﹤0.01% 1396
2015
Q4 		$13.9M Hold
63,235
– – 0.01% 1321
2015
Q3 		$12.7M Hold
63,235
– – 0.01% 1343
2015
Q2 		$9.22M Buy
+63,235
New +$7.85M ﹤0.01% 1589

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return